Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 4. Cell phase analysis of HepG2 treated with ITCs at 40 μM for 12 h; cells in G1, S, and G2/M phase (A), and flow cytometry histogram (B). Results expressed as mean ± SD (n=3).
Biomolecules & Therapeutics 2019;27:540~552 https://doi.org/10.4062/biomolther.2019.027
© Biomolecules & Therapeutics